{"id":"https://openalex.org/W2012723046","doi":"https://doi.org/10.1001/archpsyc.56.12.1101","title":"Attenuation of the Euphoric Effects of Cocaine by the Dopamine D1/D5 Antagonist Ecopipam (SCH 39166)","display_name":"Attenuation of the Euphoric Effects of Cocaine by the Dopamine D1/D5 Antagonist Ecopipam (SCH 39166)","alternate_titles":[],"publication_year":1999,"publication_date":"1999-12-01","ids":{"openalex":"https://openalex.org/W2012723046","doi":"https://doi.org/10.1001/archpsyc.56.12.1101","mag":"2012723046","pmid":"https://pubmed.ncbi.nlm.nih.gov/10591286"},"language":"en","primary_location":{"id":"doi:10.1001/archpsyc.56.12.1101","doi":"https://doi.org/10.1001/archpsyc.56.12.1101","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.56.12.1101","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012723046"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109204727","display_name":"Myroslava K. Romach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1323843004","display_name":"Sunnybrook Health Science Centre","ror":"https://ror.org/03wefcv03","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1323843004"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Myroslava K. Romach","raw_affiliation_strings":["Psychopharmacology and Dependence Research Unit, Centre for Research in Women's Health, Sunnybrook and Women's College Health Sciences Centre, Women's College Campus, Toronto, Ontario, Canada. myroslava.romach@utoronto.ca"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychopharmacology and Dependence Research Unit, Centre for Research in Women's Health, Sunnybrook and Women's College Health Sciences Centre, Women's College Campus, Toronto, Ontario, Canada. myroslava.romach@utoronto.ca","institution_ids":["https://openalex.org/I1323843004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022110262","display_name":"Paul Glue","orcid":"https://orcid.org/0000-0002-7305-2800","observed_orcids":["https://orcid.org/0000-0002-7305-2800"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Glue","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014550063","display_name":"Kyle Matthew Kampman","orcid":"https://orcid.org/0000-0002-9760-8324","observed_orcids":["https://orcid.org/0000-0002-9760-8324"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kyle Kampman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103489619","display_name":"Howard L. Kaplan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Howard L. Kaplan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072951311","display_name":"Gail R. Somer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gail R. Somer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083287516","display_name":"Sabrina A. Poole","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sabrina Poole","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Laura Clarke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laura Clarke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046810903","display_name":"Vicki L. Coffin","orcid":"https://orcid.org/0000-0001-5657-9646","observed_orcids":["https://orcid.org/0000-0001-5657-9646"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vicki Coffin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053736945","display_name":"James Cornish","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James Cornish","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086354155","display_name":"Charles P. O\u2019Brien","orcid":"https://orcid.org/0000-0002-8206-9831","observed_orcids":["https://orcid.org/0000-0002-8206-9831"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charles P. O'Brien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013791504","display_name":"Edward M. Sellers","orcid":"https://orcid.org/0000-0002-0669-2373","observed_orcids":["https://orcid.org/0000-0002-0669-2373"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edward M. Sellers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0833,"has_fulltext":false,"cited_by_count":136,"citation_normalized_percentile":{"value":0.92828066,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"56","issue":"12","first_page":"1101","last_page":"1101"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine","display_name":"cocaine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/ecopipam","display_name":"ecopipam","score":0.9829999804496765},{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.675000011920929},{"id":"https://openalex.org/keywords/euphoria","display_name":"euphoria","score":0.6570000052452087},{"id":"https://openalex.org/keywords/cocaine-craving","display_name":"cocaine craving","score":0.5509999990463257},{"id":"https://openalex.org/keywords/cocaine-reward","display_name":"cocaine reward","score":0.4959999918937683},{"id":"https://openalex.org/keywords/mesolimbic-dopamine-system","display_name":"mesolimbic dopamine system","score":0.7829999923706055},{"id":"https://openalex.org/keywords/subjective-effects-of-cocaine","display_name":"subjective effects of cocaine","score":0.6470000147819519},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7020000219345093},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.4050000011920929}],"concepts":[{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.68740314245224},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6541459560394287},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.62059485912323},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6053967475891113},{"id":"https://openalex.org/C25876315","wikidata":"https://www.wikidata.org/wiki/Q15197465","display_name":"Neurochemical","level":2,"score":0.582184374332428},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5762227177619934},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5243435502052307},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5045450925827026},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.49258047342300415},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.4544530212879181},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4023857116699219},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3645413815975189},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.27166590094566345},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2403285801410675},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2004404366016388},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.18386664986610413},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.12990465760231018},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.06730493903160095},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D003042","descriptor_name":"Cocaine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005059","descriptor_name":"Euphoria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012201","descriptor_name":"Reward","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D016739","descriptor_name":"Behavior, Addictive","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D019970","descriptor_name":"Cocaine-Related Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/archpsyc.56.12.1101","doi":"https://doi.org/10.1001/archpsyc.56.12.1101","is_oa":false,"landing_page_url":"https://doi.org/10.1001/archpsyc.56.12.1101","pdf_url":null,"source":{"id":"https://openalex.org/S126359496","display_name":"Archives of General Psychiatry","issn_l":"0003-990X","issn":["0003-990X","1538-3636"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of General Psychiatry","raw_type":"journal-article"},{"id":"pmid:10591286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10591286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives of general psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322015","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1909055455","https://openalex.org/W1943544645","https://openalex.org/W1966795950","https://openalex.org/W1970238016","https://openalex.org/W1980110193","https://openalex.org/W1990892522","https://openalex.org/W1995838778","https://openalex.org/W1998810827","https://openalex.org/W2007689138","https://openalex.org/W2014847253","https://openalex.org/W2018330782","https://openalex.org/W2038722620","https://openalex.org/W2046194410","https://openalex.org/W2052773891","https://openalex.org/W2061161259","https://openalex.org/W2075560932","https://openalex.org/W2077707065","https://openalex.org/W2080974839","https://openalex.org/W2091200481","https://openalex.org/W2092730555","https://openalex.org/W2094554392","https://openalex.org/W2095217951","https://openalex.org/W2125010305","https://openalex.org/W2146835230","https://openalex.org/W2165398609","https://openalex.org/W2258636394"],"related_works":["https://openalex.org/W2043618845","https://openalex.org/W2066310899","https://openalex.org/W2316917801","https://openalex.org/W2018933069","https://openalex.org/W2092730555","https://openalex.org/W2055461183","https://openalex.org/W2098310243","https://openalex.org/W2018330782","https://openalex.org/W4403673348","https://openalex.org/W2112215110"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,134],"subjective":[2,53],"and":[3,35,110,115,127,139,174,192],"reinforcing":[4],"effects":[5,37,43,144,194],"of":[6,15,28,38,44,88,102,105,145,157,195],"cocaine":[7,39,57,62,106,125,146,161,171,196],"in":[8,19,32,58,72,149,168,188,197],"humans":[9],"are":[10],"associated":[11],"with":[12,61,77,170],"the":[13,20,26,33,42,45,189],"enhancement":[14],"endogenous":[16],"dopamine":[17,29],"function":[18],"mesolimbic":[21],"system.":[22],"This":[23],"study":[24],"examined":[25],"role":[27,184],"D1-like":[30,186],"receptors":[31,187],"behavioral":[34],"mood":[36],"by":[40,66,153],"evaluating":[41],"selective":[46],"D1/D5":[47],"antagonist":[48],"ecopipam":[49,89],"(SCH":[50],"39166)":[51],"on":[52,91],"responses":[54,112],"to":[55,124,159],"intravenous":[56,100],"11":[59],"subjects":[60],"dependence":[63],"as":[64],"defined":[65],"DSM-IV.":[67],"METHODS:":[68],"Subjects":[69],"were":[70,113,121,147,162],"pretreated":[71],"a":[73,98,150,181],"randomized":[74],"double-blind":[75],"fashion":[76],"either":[78],"placebo":[79],"or":[80,85],"10":[81],"mg,":[82,84],"25":[83],"100":[86],"mg":[87,104],"orally":[90],"4":[92],"separate":[93],"occasions.":[94],"Two":[95],"hours":[96],"later":[97],"single":[99],"injection":[101],"30":[103],"was":[107,172],"administered.":[108],"Subjective":[109],"cardiovascular":[111],"measured":[114],"blood":[116],"samples":[117],"for":[118,185],"pharmacokinetic":[119],"evaluation":[120],"obtained":[122],"prior":[123],"dosing":[126],"at":[128],"various":[129],"times":[130],"after":[131],"dosing.":[132],"RESULTS:":[133],"euphoric":[135],"(P":[136,141,164],"=":[137,142,165],".004)":[138],"stimulating":[140],".03)":[143],"attenuated":[148],"dose-dependent":[151],"manner":[152],"ecopipam,":[154],"while":[155],"ratings":[156],"desire":[158],"take":[160],"diminished":[163],".02).":[166],"Ecopipam":[167],"combination":[169],"safe":[173],"well":[175],"tolerated.":[176],"CONCLUSION:":[177],"These":[178],"data":[179],"indicate":[180],"potentially":[182],"important":[183],"acute":[190],"mood-altering":[191],"rewarding":[193],"humans.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012723046","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
